전체 프로그램

ADCBiologicstaleMonopar TherapeuticsPreclinical

MNPR-101-PCTA-177Lu (MNPR-101-PCTA-177Lu)

Cancer; Solid Tumor · Cancer

#Cancer#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+2

AntibodystaleMonopteros Therapeutics Inc.Phase 1

pembrolizumab (Keytruda, MPT-0118 + pembrolizumab)

Solid Tumor, Adult; Advanced Solid Tumor · FRα

#FR#Antibody#Phase1#항체#면역항체+5

ADCBiologicstaleShanghai Miracogen Inc.Phase 2

MRG002+HX008 (MRG002+HX008)

Advanced Malignant Solid Tumors · Advanced Malignant Solid Tumors

#AdvancedMalignantSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleShanghai Miracogen Inc.Phase 2

MRG003+HX008 (MRG003+HX008)

Advanced Solid Tumors · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

ADCBiologicstaleLepu Biopharma Co., Ltd.Phase 2

MRG004A (MRG004A)

Advanced or Metastatic Solid Tumors · Advanced or Metastatic Solid Tumors

#AdvancedorMetastaticSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1

CGTBiologicstaleMemorial Sloan Kettering Cancer…Phase 1

MSK-TCR5 (MSK-TCR5)

Solid Tumor; Solid Carcinoma · Solid Tumor

#SolidTumor#CGT#Phase1#세포유전치료#CAR-T+3

CGTBiologicstaleCancer Institute and Hospital, …Phase 2

Meta10-TIL (Meta10-TIL)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#CGT#Phase2#세포유전치료#CAR-T+3

ADCBiologicstaleNBE-Therapeutics AGPhase 2

NBE-002 (NBE-002)

Advanced Solid Tumor; Advanced Cancer · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2

임상시험 1상태 DISCONTINUED

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

NEOK001 (NEOK001)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

NEOK001 RDE (NEOK001 RDE)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

NEOK002 (NEOK002)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

#LocallyAdvancedUnresectableorMet#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1

NEOK002 RDE (NEOK002 RDE)

Locally Advanced (Unresectable) or Metastatic Solid Tumors · Locally Advanced (Unresectable) or Metas

CGTBiologicstaleGuangzhou Xiling Biotechnology …Phase 1

NK cell preparation (NK cell preparation)

Advanced Solid Tumors (Phase 1) · Advanced Solid Tumors (Phase 1)

#AdvancedSolidTumorsPhase1#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleZhejiang UniversityPhase 1

NKG2D CAR NK and NKG2D CAR T cells (NKG2D CAR NK and NKG2D CAR T cells)

Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments · Patients With Advanced Solid Tumors With

#PatientsWithAdvancedSolidTumorsW#CGT#Phase1#세포유전치료#CAR-T+2

CGTBiologicstaleUniversity of ChicagoPhase 2

NY-ESO-1 TCR/ dnTGFβRII (NY-ESO-1 TCR/ dnTGFβRII)

Ovarian Cancer; Advanced Malignant Solid Tumor · Ovarian Cancer

#OvarianCancer#CGT#Phase2#세포유전치료#CAR-T+3

CGTBiologicstalePACT Pharma, Inc.Phase 1

NeoTCR-P1 adoptive cell therapy (NeoTCR-P1 adoptive cell therapy)

Solid Tumor · Solid Tumor

#SolidTumor#CGT#Phase1#세포유전치료#CAR-T+2

임상시험 1상태 DISCONTINUED

ADCBiologicstaleOBI Pharma, IncPhase 2

OBI-902 (OBI-902)

Advanced Solid Tumor · Advanced Solid Tumor

#AdvancedSolidTumor#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1